VitaNova Life Sciences (VNOV) Change in Receivables (2024 - 2026)

VitaNova Life Sciences has reported Change in Receivables for 3 years, with the latest figure at $225537.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Receivables changed N/A year-over-year to $225537.0; the trailing twelve-month figure through Jan 2026 stood at -$671782.0 (down 200.0% YoY), and the FY2025 full-year result was -$302068.0, down 165.54% from the prior year.
• Change in Receivables for Q1 2026 stood at $225537.0, up from -$384339.0 in the prior quarter.
• The five-year high for Change in Receivables was $460870.0 in Q2 2024, with the low at -$512980.0 in Q2 2025.
• Historically, Change in Receivables has averaged $0.0 across 3 years, with a median of $210912.0 in 2024.
• The largest YoY upside for Change in Receivables was 211.31% in 2025 against a maximum downside of 282.23% in 2025.
• VitaNova Life Sciences' Change in Receivables stood at $210912.0 in 2024, then slumped by 282.23% to -$384339.0 in 2025, then jumped by 158.68% to $225537.0 in 2026.
• The last three Change in Receivables figures came in at $225537.0 (Q1 2026), -$384339.0 (Q4 2025), and -$512980.0 (Q2 2025), per Business Quant data.